Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Fosun Health Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$13M
Portfolio companies 7
Rounds per year 2.25
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.22
Key employees Soon

Areas of investment

  • Medical
  • Pharmaceutical
  • Health Care
  • Biopharma
  • Cosmetic Surgery

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Celregen Therapeutics

14 Sep 2024 Shanghai, Shanghai, China

Shengbao Bio

Biotechnology
Medical
Pharmaceutical
26 Jul 2024 Shenzhen, Guangdong, China

Conjustar

Health Care
Medical
Pharmaceutical
$13M30 Jan 2024 Shanghai, Shanghai, China

AIMIRA Innovation Technology

Artificial Intelligence
Cosmetic Surgery
Medical
$15M05 Sep 2023 Guangzhou, Guangdong, China

Atantares Corp.

Health Diagnostics
Machine Learning
Semiconductor
$15M31 Jul 2023 Cambridge, Massachusetts, United States

Boao Mingsai

Biopharma
Pharmaceutical
$30M18 May 2023 Suzhou, Jiangsu, China

Conjustar

Health Care
Medical
Pharmaceutical
$8M23 Feb 2023 Shanghai, Shanghai, China

Chaomu Technology

Eyewear
Health Care
Medical
$13M07 Dec 2022
Changping, Beijing, China

Boao Mingsai

Biopharma
Pharmaceutical
$25M01 Sep 2020 Suzhou, Jiangsu, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Fosun Health Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 9
Average round size 13M
Rounds per year 2.25
Peak activity year 2023
Lead investments 2
Follow on index 0.22
Group Appearance index 0.78

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Celregen Therapeutics

14 Sep 2024 Shanghai, Shanghai, China

Shengbao Bio

Biotechnology
Medical
Pharmaceutical
26 Jul 2024 Shenzhen, Guangdong, China

Conjustar

Health Care
Medical
Pharmaceutical
$13M30 Jan 2024 Shanghai, Shanghai, China

AIMIRA Innovation Technology

Artificial Intelligence
Cosmetic Surgery
Medical
$15M05 Sep 2023 Guangzhou, Guangdong, China

Atantares Corp.

Health Diagnostics
Machine Learning
Semiconductor
$15M31 Jul 2023 Cambridge, Massachusetts, United States

Boao Mingsai

Biopharma
Pharmaceutical
$30M18 May 2023 Suzhou, Jiangsu, China

Conjustar

Health Care
Medical
Pharmaceutical
$8M23 Feb 2023 Shanghai, Shanghai, China

Chaomu Technology

Eyewear
Health Care
Medical
$13M07 Dec 2022
Changping, Beijing, China

Boao Mingsai

Biopharma
Pharmaceutical
$25M01 Sep 2020 Suzhou, Jiangsu, China
Crunchbase icon

Content report

The following text will be sent to our editors: